article thumbnail

What is a Trademark Registration “Presentation Copy”?

Erik K Pelton

The following is an edited transcript of my video What is a Presentation Copy of a Trademark Registration? If your application came along after that, you have to pay a small fee to get the presentation copy. My concern is that the presentation copy is not valuable. The presentation copy falls a little short in my opinion.

Copying 147
article thumbnail

What is a Presentation Copy of a Trademark Registration?

Erik K Pelton

What are the differences between a USPTO trademark registration certificate and a presentation copy? Erik explains the differences between electronic, presentation, and paper registration certificates. The post What is a Presentation Copy of a Trademark Registration? appeared first on Erik M Pelton & Associates, PLLC.

Copying 147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Astellas Case Highlights Patent Eligibility Under Section 101 and the Party Presentation Principle

JD Supra Law

The Federal Circuit decision affirmed the applicability of the party presentation principle with respect to issues of patent eligibility under Section 101; as with other grounds of invalidity, the district court’s role in patent eligibility is limited to determining whether. Sandoz Inc.,

Patent 68
article thumbnail

Journey Through “Mays” on SpicyIP (2005 – Present) 

SpicyIP

Overall, with layers of intrigue, secrecy, and questionable practices, the complex relationship between IP law, CSIR, and the ever-present quest for accountability is worth remembering when thinking of the larger scheme of IP things. Generally, the benchmark for comparative advertising hinges on the “average consumer” test.

article thumbnail

Phil Johnson Presented with Second Annual Pauline Newman Award; Newman and Quinn Question the Future of the CAFC

IP Watchdog

On the final day of IPWatchdog LIVE 2024, Phil Johnson became the second recipient of the annual Pauline Newman Award, which is presented each year to recognize the unique achievements of one patent attorney over their career.

Patent 111
article thumbnail

Alvotech and Teva Announce FDA Approval of Additional Presentation for Ustekinumab Biosimilar

JD Supra Law

On October 22, 2024, Alvotech and Teva announced that SELARSDI™ (ustekinumab-aekn) received FDA approval for a new presentation, 130 mg/26 mL (5 mg/mL) solution in a single-dose vial for intravenous infusion. By: Goodwin

70
article thumbnail

Presenting Complicated Technology Effectively at the PTAB

JD Supra Law

The PTAB recently hosted a Boardside Chat on effectively presenting technology in AIA proceedings. Patent Trial and Appeal Board Boardside Chat: Presenting Technology in AIA Proceedings, (Nov. 17, 2022) (“Presenting Technology”).